The Expanding Role of Immunotherapy in Bladder Cancer Treatment
Accredited for 1.0 CME Credit
Estimated Time to Complete: 1 Hour
NOTE: No personal payment information is collected during checkout
The goal of this educational program is to equip urologists, medical oncologists, radiation oncologists, and other healthcare providers nationwide who are involved in the treatment of patients with bladder cancer with the up-to-date clinical knowledge and tools they need to best diagnose and treat their patients. With growing advancements in immunotherapy treatment of bladder cancer, patients may experience better treatment outcomes.